Alzheimer's disease (AD) is the most frequent case of neurodegenerative disease and is
becoming a major public health problem all over the world. Many therapeutic strategies …

The Organ-on-a-Chip (OoC) technology shows great potential to revolutionize the drugs
development pipeline by mimicking the physiological environment and functions of human …

Alzheimer's disease (AD) is a devastating neurodegenerative disorder affecting the aging
population. Despite many studies, there remains an urgent need to identify the root causes …

Self-assembling peptide-based hydrogels have become a highly attractive scaffold for three-
dimensional (3D) in vitro disease modeling as they provide a way to create tunable matrices …

Parkinson's disease (PD) and Alzheimer's disease (AD) are neurodegenerative disorders
caused by the interaction of genetic, environmental, and familial factors. These diseases …

Alzheimer's disease (AD) is a progressive, neurodegenerative disease that has emerged as
a leading risk factor for dementia associated with increasing age. Two‐dimensional (2D) cell …

Neuronal miRNA dysregulation may have a role in the pathophysiology of Alzheimer's
disease (AD). miRNA (miR)-124 is largely abundant and a critical player in many neuronal …

The presenilin genes (PSEN1 and PSEN2) are mainly responsible for causing early-onset
familial Alzheimer's disease, harboring~ 300 causative mutations, and representing~ 90% of …

To date, although the microscopic alterations present in Alzheimer's disease (AD) have
been well known for over a century only a handful of symptomatic treatments have been …

Alzheimer's disease is a neurological disorder marked by the accumulation of amyloid beta
(Aβ) aggregates, resulting from mutations in the amyloid precursor protein. The enzyme β …